Evidence map›Paper›PMID 34021256›Full record

ArticleCommunications biology2021

Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury.

Anna K Uryga, Mandy O J Grootaert, Abel M Garrido, Sebnem Oc, Kirsty Foote, Joel Chappell, Alison Finigan, Francesca Rossiello, Fabrizio d'Adda di Fagagna, Dimitra Aravani and 2 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. The epigenetic and epitranscriptomic regulation of Brd4-Mettl3 axis on STING mediated vascular calcification.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Decoding Vascular Senescence: Cellular Insights and Therapeutic Strategies.International journal of biological sciences · 2026
    Review
  16. Review
  17. Review
  18. Aging and lung diseases: Unraveling mechanisms and therapeutic targets.Chinese medical journal pulmonary and critical care medicine · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Anna K Uryga *Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Mandy O J Grootaert *Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Abel M GarridoDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Sebnem OcDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Kirsty FooteDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Joel ChappellDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.ORCID 0000-0002-5834-4100
Alison FiniganDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Francesca RossielloFIRC Institute of Molecular Oncology Foundation, IFOM Foundation, Milan, Italy.
Fabrizio d'Adda di FagagnaFIRC Institute of Molecular Oncology Foundation, IFOM Foundation, Milan, Italy.
Dimitra AravaniDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.
Helle F JorgensenDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK.ORCID 0000-0002-7909-2977
Martin R BennettDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, UK. mrb24@medschl.cam.ac.uk.ORCID 0000-0002-2565-1825
University of Cambridge · GBIFOM · IT

Funding

British Heart Foundation CH/2000003/12800British Heart Foundation PG/13/25/30014British Heart Foundation PG/16/11/32021British Heart Foundation PG/16/24/32090British Heart Foundation PG/19/6/34153British Heart Foundation RG/08/009/25841British Heart Foundation RG/13/14/30314British Heart Foundation RG/20/2/34763British Heart Foundation RG71070British Heart Foundation RG84554
6 · The paper itself

Abstract

Accumulation of vascular smooth muscle cells (VSMCs) is a hallmark of multiple vascular pathologies, including following neointimal formation after injury and atherosclerosis. However, human VSMCs in advanced atherosclerotic lesions show reduced cell proliferation, extensive and persistent DNA damage, and features of premature cell senescence. Here, we report that stress-induced premature senescence (SIPS) and stable expression of a telomeric repeat-binding factor 2 protein mutant (TRF2

Indexed as

Cellular SenescenceAnimalsAtherosclerosisCell ProliferationCells, CulturedDisease Models, AnimalDNA DamageHumansInflammationMaleMiceMice, Inbred C57BLMice, KnockoutMicrofilament ProteinsMuscle ProteinsMuscle, Smooth, VascularMicrofilament ProteinsMuscle ProteinsTagln protein, mouseTelomeric Repeat Binding Protein 2TERF2 protein, human

Identifiers

PMID34021256
PMCPMC8140103
OpenAlexW3162650947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.